Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics Ltd (TSE:VPT)
:VPT
RESEARCH TOOLSreports
Total Valuation
VentriPoint Diagnostics has a market cap or net worth of C$25.04M. The enterprise value is C$27.62M.
Market CapC$25.04M
Enterprise ValueC$27.62M
Share Statistics
VentriPoint Diagnostics has 166,933,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding166,933,530
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
VentriPoint Diagnostics’s return on equity (ROE) is 1.65 and return on invested capital (ROIC) is 350.53%.
Return on Equity (ROE)1.65
Return on Assets (ROA)-7.48
Return on Invested Capital (ROIC)350.53%
Return on Capital Employed (ROCE)1.73
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.14
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio-7.13
Price to Fair Value-5.31
Price to FCF-9.15
Price to Operating Cash Flow-8.92
PEG Ratio-0.98
Income Statement
In the last 12 months, VentriPoint Diagnostics had revenue of 95.17K and earned -4.92M in profits. Earnings per share was -0.03.
Revenue95.17K
Gross Profit95.17K
Operating Income-4.80M
Pretax Income-5.00M
Net Income-4.92M
EBITDA-4.76M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -2.83M and capital expenditures -4.00, giving a free cash flow of -2.83M billion.
Operating Cash Flow-2.83M
Free Cash Flow-2.83M
Free Cash Flow per Share-0.02
Dividends & Yields
VentriPoint Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change-25.00%
50-Day Moving Average0.13
200-Day Moving Average0.13
Relative Strength Index (RSI)55.65
Average Volume (3m)200.49K
Important Dates
VentriPoint Diagnostics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
VentriPoint Diagnostics as a current ratio of 0.14, with Debt / Equity ratio of -60.21%
Current Ratio0.14
Quick Ratio0.14
Debt to Market Cap0.09
Net Debt to EBITDA-0.33
Interest Coverage Ratio-25.65
Taxes
In the past 12 months, VentriPoint Diagnostics has paid -83.47K in taxes.
Income Tax-83.47K
Effective Tax Rate0.02
Enterprise Valuation
VentriPoint Diagnostics EV to EBITDA ratio is -3.66, with an EV/FCF ratio of -5.14.
EV to Sales182.85
EV to EBITDA-3.66
EV to Free Cash Flow-5.14
EV to Operating Cash Flow-5.14
Balance Sheet
VentriPoint Diagnostics has C$352.67K in cash and marketable securities with C$2.13M in debt, giving a net cash position of C$1.78M billion.
Cash & Marketable SecuritiesC$352.67K
Total DebtC$2.13M
Net CashC$1.78M
Net Cash Per ShareC$0.01
Tangible Book Value Per Share-C$0.02
Margins
Gross margin is 90.68%, with operating margin of -5045.41%, and net profit margin of -5169.14%.
Gross Margin90.68%
Operating Margin-5045.41%
Pretax Margin-5256.85%
Net Profit Margin-5169.14%
EBITDA Margin-5001.96%
EBIT Margin-5068.02%
Analyst Forecast
The average price target for VentriPoint Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast280.56%
EPS Growth Forecast-7.28%